jueves, 4 de septiembre de 2025

FDA Approves Drug to Treat Adults with Persistent or Chronic Immune Thrombocytopenia

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-treat-adults-persistent-or-chronic-immune-thrombocytopenia

No hay comentarios:

Publicar un comentario